AngioScore's Acquisition

AngioScore was acquired by Spectranetics on June 30, 2014.

AngioScore designs, develops, manufactures and markets scoring balloon catheters to treat cardiovascular and peripheral artery diseases. It offers AngioSculpt RX, a rapid exchange coronary scoring dev…

Articles about AngioScore's Acquisition: